Publications

HIV infection and the duration and control of prevalent tuberculosis disease in Harare, Zimbabwe.

CORBETT, E; Bandason, T; Dauya, E; Makamure, B; Cheung, Y.-, B; Mtero-Munyati, S; Matambo, R; GODFREY-FAUSSETT, P; HAYES, R; Churchyard, G; Butterworth, A; Mason, P;

2005

TRSU (2005).

A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to Bacille Calmette-Guérin (BCG) immunisation [ISRCTN32849447].

ELLIOTT, AM; Namujju, PB; MAWA, PA; Quigley, MA; Nampijja, M; Nkurunziza, PM; Belisle, JT; Muwanga, M; WHITWORTH, JA G; Mother and Baby study team,;

2005

BMC infectious diseases, (2005).5 1 10.1186/1471-2334-5-115.

Immune responses induced by infant BCG vaccination in Malawi and the UK.

Ben-Smith, A; Lalor, MK; Weir, RE; GORAK-STOLINSKA, P; FLOYD, S; Makamo, K; BLITZ, R; Mvula, H; Newport, MJ; BRANSON, K; Jahn, A; CRAMPIN, AC; FINE, PE; DOCKRELL, HM;

2005

Immunology, (2005).116,

Stopping routine vaccination for tuberculosis in schools.

FINE, P;

2005

BMJ, (2005).331 7518 10.1136/bmj.331.7518.647.

Does traditional medicine use hamper efforts at tuberculosis control in urban Peru?.

Oeser, CC; Escombe, AR; Gilman, RH; Friedland, JS; Evans, CA W; MOORE, DA J;

2005

The American journal of tropical medicine and hygiene, (2005).73 3 10.4269/ajtmh.2005.73.571.

Tuberculosis skin testing, anergy and protein malnutrition in Peru.

Pelly, TF; Santillan, CF; Gilman, RH; Cabrera, LZ; Garcia, E; Vidal, C; Zimic, MJ; MOORE, DA J; Evans, CA;

2005

The international journal of tuberculosis and lung disease, (2005).9 9

Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment.

FERRAND, RA; Bothamley, GH; Whelan, A; DOCKRELL, HM;

2005

The international journal of tuberculosis and lung disease, (2005).9 9

Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.

Grode, L; Seiler, P; Baumann, S; Hess, J; Brinkmann, V; Nasser Eddine, A; Mann, P; Goosmann, C; Bandermann, S; Smith, D; BANCROFT, GJ; Reyrat, J-M; Van Soolingen, D; Raupach, B; Kaufmann, SH E;

2005

The Journal of clinical investigation, (2005).115 9 10.1172/JCI24617.

Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma.

KAMPMANN, B; Hemingway, C; Stephens, A; Davidson, R; Goodsall, A; Anderson, S; Nicol, M; Schölvinck, E; Relman, D; Waddell, S; Langford, P; Sheehan, B; Semple, L; Wilkinson, KA; Wilkinson, RJ; Ress, S; HIBBERD, M; Levin, M;

2005

The Journal of clinical investigation, (2005).115 9 10.1172/JCI19316.

Mycobacteriophage and their application to disease control.

MCNERNEY, R; Traoré, H;

2005

Journal of applied microbiology, (2005).99 2 10.1111/j.1365-2672.2005.02596.x.